AI
NXTC icon

Acuitas Investments’s NextCure NXTC Stock Holding History

Acuitas Investments’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,549
Closed -$469K – 104
2024
Q3 		$469K Buy
28,549
+1,604
+6% +$29.5K 0.21% 102
2024
Q2 		$514K Buy
26,945
+140
+0.5% +$2.72K 0.28% 98
2024
Q1 		$717K Sell
26,805
-4,262
-14% -$73.4K 0.36% 81
2023
Q4 		$492K Buy
31,067
+7,166
+30% +$104K 0.26% 97
2023
Q3 		$370K Sell
23,901
-2
-0% -$38 0.22% 97
2023
Q2 		$516K Buy
+23,903
New +$471K 0.3% 84

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acuitas Investments's NXTC Position: Q4 2024 in Review

Acuitas Investments sold out of NextCure (NXTC) in Q4 2024, closing a stake of 28,549 shares — an estimated $469K sold.

Acuitas Investments first reported a position in NXTC in Q2 2023 and held it in 6 quarters. The position peaked at $717K in Q1 2024. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2024.

  • Acuitas Investments reported no remaining NextCure position as of Q4 2024 after selling out during the quarter.
  • Acuitas Investments sold 28,549 NextCure shares in Q4 2024, an estimated $469K.
  • Acuitas Investments first reported a position in NextCure in Q2 2023 and held it in 6 quarters.
  • Acuitas Investments's NextCure position peaked at $717K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2024.

Based on Acuitas Investments's 13F filing for Q4 2024, filed 31 Jan 2025.